HPS Pharmacies prides itself on providing innovative and informative support to assist in the diverse range of issues health professionals face on a day-to-day basis, and to facilitate the distribution of this information for a variety of sectors within the healthcare industry.
HPS’ clinical articles are written by HPS Pharmacies’ experienced and knowledgeable staff and are peer-reviewed by specialist leaders in their field to ensure the accuracy of the information provided. The resourceful and diverse range of articles play an integral role in keeping all health professionals up-to-date with the happenings throughout the industry on a regular basis.
The Australian Commission on Safety and Quality in Healthcare recently released the Chronic Obstructive Pulmonary Disease Clinical Care Standard. This is the first national standard on chronic obstructive pulmonary disease (COPD), a common condition…
Read more
People with diabetes are at a greater risk of many infections. This includes infections of the urinary tract, respiratory tract, skin and soft tissues. Infections are a significant cause of morbidity and mortality in…
Read more
Antiemetics can be used to treat or prevent nausea and vomiting due to a range of causes. Their use can significantly improve quality of life and prevent complications such as dehydration and electrolyte disturbances….
Read more
The scheduling of paracetamol will change on 1 February 2025, affecting pack sizes and how paracetamol-containing products can be accessed. These changes are intended to minimise harm related to intentional paracetamol overdose while…
Read more
“Health literacy means being able to access, understand, appraise and use information and services in ways that promote and maintain good health and well-being.” WHO 2024 The term “health literacy” has a long history….
Read more
World Antimicrobial Resistance (AMR) Awareness Week is celebrated each year from the 18th to the 24th of November. This campaign aims to raise awareness and understanding of AMR, with the ultimate goal of improving…
Read moreNational Standard for Chronic Obstructive Pulmonary Disease (Jan. 24 2025)
Urinary Tract Infections and Diabetes Mellitus (Jan. 10 2025)
Antiemetics (Dec. 27 2024)
Upcoming Changes to Paracetamol Scheduling (Dec. 13 2024)
Dementia Literacy (Nov. 29 2024)
Allergies and Antimicrobial Resistance (Nov. 15 2024)
Respiratory Syncytial Virus (Nov. 01 2024)
Antibiotic-Associated Diarrhoea (Oct. 18 2024)
Medicines and Breastfeeding (Oct. 04 2024)
Safe Use of High-Risk Medications (Sep. 20 2024)
Benzyl Alcohol in Pharmaceutical Products (Sep. 06 2024)
Semaglutide for Weight Management (Aug. 23 2024)
Medication-Induced Taste Disorders (Aug. 09 2024)
Respiratory Syncytial Virus (Jul. 26 2024)
Overview of cephalosporins (Jul. 05 2024)
Iron Infusions (Jun. 21 2024)
Sulfites in Pharmaceutical Products (Jun. 07 2024)
Potentially Inappropriate Medicines in the Australian Setting (May. 24 2024)
Intranasal Corticosteroids in Allergic Rhinitis (May. 10 2024)
Updated COVID-19 Vaccine Recommendations (Apr. 26 2024)
Medication-Overuse Headache (Apr. 12 2024)
Data and Decisions for the Three Different CDK4/6 Inhibitors (Mar. 29 2024)
Changes Affecting Submissions for Unapproved Therapeutic Goods (Mar. 15 2024)
Pneumoccoccal Vaccines (Mar. 01 2024)
Potential Anaesthesia Risk with GLP-1 Agonists (Feb. 16 2024)
Mycobacterium bovis BCG for Bladder Cancer (Feb. 02 2024)
Patient Deterioration in the Healthcare Setting (Jan. 19 2024)
Comparison of different types of G-CSF (Jan. 05 2024)
Medications for the Management of Urinary Incontinence (Dec. 22 2023)
Oral Therapies in Metastatic Prostate Cancer (Dec. 08 2023)
Antifungal Resistance (Nov. 24 2023)
Evidence-based Non-drug Treatments in Dementia – Reminiscence Therapy (Nov. 10 2023)
An Overview of Fungi (Oct. 27 2023)
Lower Urinary Tract Symptoms in Men (Oct. 13 2023)
Weight Loss Medications (Sep. 29 2023)
Revised Hip Fracture Clinical Care Standard (Sep. 15 2023)
Antibiotic Use in the Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease (Sep. 01 2023)
Erythropoietin Resistance (Aug. 18 2023)
Amiodarone-induced Thyroid Disorders (Aug. 04 2023)
Biological Therapies for Rheumatoid Arthritis (Jul. 21 2023)
Mineralocorticoid Receptor Antagonists (Jul. 07 2023)
Neo-Adjuvant Treatment of Melanoma and Directed Therapy from the PRADO Trial (Jun. 23 2023)
Anticoagulant-Related Nephropathy (Jun. 09 2023)
Sepsis (May. 26 2023)
Patient Self-Management (May. 12 2023)
The Role of the Pharmacist in Survivorship Care (Apr. 28 2023)
Recurrent Urinary Tract Infections in Women (Apr. 14 2023)
Enerzair® Breezhaler® (Mar. 31 2023)
Tirzepatide: a New Treatment for Type 2 Diabetes and Weight Loss (Mar. 17 2023)
Vedolizumab and Ustekinumab for the Treatment of Crohn’s Disease (Mar. 03 2023)
Wernicke-Korsakoff Syndrome (Feb. 17 2023)
Gestational Diabetes (Feb. 03 2023)
Glucagon-like Peptide-1 Receptor Agonists (Jan. 20 2023)
The Clinical Merits Associated with Utilising a Prescribing Pharmacist (Jan. 06 2023)
Improving Medication Use at Transitions of Care (Dec. 23 2022)
Vericiguat for Heart Failure (Dec. 09 2022)
Probiotics for Preterm Infants (Nov. 25 2022)
Updated Recommendations for the Dosing of Anticancer Drugs in Kidney Dysfunction (Nov. 11 2022)
Solid Oral Dose Forms and Swallowing Difficulties (Oct. 28 2022)
Vancomycin Use in Arthroplasty Patients (Oct. 14 2022)
Drug Holidays from Bisphosphonates (Sep. 30 2022)
Iron Deficiency Anaemia (Sep. 16 2022)
Drug-induced QT Interval Prolongation (Sep. 02 2022)
Monkeypox in Australia (Aug. 19 2022)
Anticholinergic Burden (Aug. 05 2022)
New Therapy for Cystic Fibrosis (Apr. 29 2022)
Seasonal Influenza Vaccination (Apr. 14 2022)
Paroxysmal Nocturnal Haemoglobinuria (Apr. 01 2022)
Aged Care and Chemical Restraint (Mar. 18 2022)
Molnupiravir for COVID-19 (Mar. 04 2022)
SGLT2 Inhibitors for Heart Failure (Feb. 18 2022)
COVID-19 Treatment Options (Feb. 04 2022)
What is Cancer Survivorship Care? (Jan. 21 2022)
Managing the Side Effects of Chemotherapy (Dec. 31 2021)
COVID-19 Vaccine Boosters (Dec. 17 2021)
Glucagon-like Peptide-1 Analogues (Dec. 03 2021)
Antimicrobial Awareness Week (Nov. 18 2021)
Restless Legs Syndrome (Nov. 05 2021)
Medication Interactions with Food (Oct. 21 2021)
Revised Delirium Clinical Care Standard (Oct. 08 2021)
Hepatitis B Reactivation (Sep. 23 2021)
Antimicrobial resistance: The need for stewardship (Sep. 08 2021)
Cannabis (Aug. 26 2021)
Melanoma – An Update in Treatment Strategies (Aug. 13 2021)
New Labelling Standard (Jul. 30 2021)
Prevention of Shingles (Jul. 16 2021)
Melatonin down scheduling: a brief update (Jul. 01 2021)
Topical treatment in psoriasis (Jun. 17 2021)
Progress of Cervical Cancer Elimination (Jun. 04 2021)
New Action Plan for Pain Management (May. 21 2021)
Thyroid Awareness Month (May. 06 2021)
Influenza Vaccines (Apr. 23 2021)
Treatment of Eosinophilic Oesophagitis (Apr. 09 2021)
Hospital-initiated Medication Reviews (Feb. 26 2021)
Boxed Warnings for Gabapentinoids (Feb. 10 2021)
COVID-19 Vaccines (Jan. 28 2021)
Updates to the Poisons Standard (Jan. 15 2021)
Active Ingredient Prescribing (Dec. 23 2020)
New Digital Mental Health Standards (Dec. 18 2020)
Approval of New Prescription Medications (Dec. 04 2020)
Antimicrobial Resistance (Nov. 20 2020)
Vaccines and Cold Chain (Nov. 06 2020)
Darolutamide (Nubeqa®) in Prostate Cancer (Oct. 22 2020)
Drugs in Sport (Oct. 09 2020)
Treatment of Infantile Haemangioma (Sep. 25 2020)
Abemaciclib for Breast Cancer (Sep. 11 2020)
Primary Cutaneous T-cell Lymphoma (Aug. 28 2020)
Gliflozins and Heart Failure (Aug. 12 2020)
Remdesivir – an emerging treatment for COVID-19 patients. (Jul. 31 2020)
Safe Injection Practices (Jul. 17 2020)
Diabetes and Insulin (Jul. 02 2020)
Hydroxychloroquine as triple therapy in COVID-19 patients (Jun. 16 2020)
Tocilizumab, COVID-19 and the cytokine storm (Jun. 03 2020)
Colchicine use in Acute Myocardial Infarction (May. 20 2020)
Changes to Opioid PBS Listings (May. 06 2020)
Coronavirus Disease (Apr. 22 2020)
Risk of Viral Transmission with Nebulised Medication Delivery (Apr. 09 2020)
Xerostomia (Feb. 27 2020)
Monoclonal Antibodies for Migraine (Feb. 13 2020)
Changes to Neural Connector Devices (Jan. 30 2020)
Venetoclax (Jan. 16 2020)
Biosimilars in Oncology (Jan. 03 2020)
Prescription Opioid Changes (Nov. 22 2019)
Diabetes Medications in the Peri-Operative Period (Nov. 08 2019)
Lamotrigine Dose Escalation (Oct. 25 2019)
Wilson Disease (Oct. 11 2019)
Parkinson’s Disease and Hospitalisation (Sep. 27 2019)
Understanding Clinical Trials (Sep. 13 2019)
Short-Course Oxycodone Packs (Aug. 30 2019)
Tafenoquine: A Novel Anti-Malarial (Aug. 16 2019)
Medicinal Marijuana? (Aug. 02 2019)
Primary Prevention: a Low-Dose Aspirin Story (Jul. 19 2019)
Hand-Foot Syndrome (Jul. 08 2019)
Low Dose Methotrexate for Rheumatoid Arthritis (Jun. 21 2019)
Introduction to the storage of medications in a private hospital setting (Jun. 07 2019)
Lactulose for Hepatic Encephalopathy (May. 24 2019)
Proton Pump Inhibitor Restrictions (May. 10 2019)
Prevention of Recurrent Clostridium difficile Infection (Apr. 25 2019)
Updates to the Australian Asthma Handbook (Apr. 12 2019)
Heparins (Mar. 29 2019)
Safety and Quality Standards for Mental Health (Mar. 15 2019)
Potentially Harmful Medication Use in the Elderly (Mar. 01 2019)
Animal-Assisted Therapy for Dementia (Feb. 15 2019)
Augmented Renal Clearance (Feb. 01 2019)
Biofilms (Jan. 18 2019)
Medications and Sun Exposure (Jan. 04 2019)
